(Q38339549)

2 September 2017

Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22. (English)

1 reference

2 September 2017

1 reference

metastatic breast cancer

1 reference

J B Patel

1

1 reference

2 September 2017

H N Appaiah

2

1 reference

2 September 2017

R M Burnett

3

1 reference

2 September 2017

P Bhat-Nakshatri

4

1 reference

2 September 2017

G Wang

5

1 reference

2 September 2017

R Mehta

6

1 reference

2 September 2017

S Badve

7

1 reference

2 September 2017

M J Thomson

8

1 reference

2 September 2017

S Hammond

9

1 reference

2 September 2017

P Steeg

10

1 reference

2 September 2017

Y Liu

11

1 reference

2 September 2017

H Nakshatri

12

1 reference

2 September 2017

language of work or name

English

0 references

publication date

8 November 2010

1 reference

2 September 2017

1 reference

2 September 2017

30

1 reference

2 September 2017

11

1 reference

2 September 2017

1290-1301

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2010.510

2 September 2017

0 references

cites work

Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Estradiol-regulated microRNAs control estradiol response in breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Widespread microRNA repression by Myc contributes to tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

miR-200 enhances mouse breast cancer cell colonization to form distant metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Tumour-cell invasion and migration: diversity and escape mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Identifying site-specific metastasis genes and functions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Prolonged glial expression of Sox4 in the CNS leads to architectural cerebellar defects and ataxia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Metastamir: the field of metastasis-regulatory microRNA is spreading

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

MicroRNA control of signal transduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

A multigenic program mediating breast cancer metastasis to bone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Strengths and limitations of laboratory procedures for microRNA detection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

The role of Runx1/AML1 and Evi-1 in the regulation of hematopoietic stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

MicroRNAs--the micro steering wheel of tumour metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

MicroRNAs and their target gene networks in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

A molecular signature of metastasis in primary solid tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

X chromosomal abnormalities in basal-like human breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

The humoral immune system has a key prognostic impact in node-negative breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Tumor metastasis: mechanistic insights and clinical challenges

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Endogenous human microRNAs that suppress breast cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

Induced pluripotent stem cell lines derived from human somatic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.510

31 March 2020

Identifiers

DOI

10.1038/ONC.2010.510

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference